HSK-31858

N/A

Report date: 2026/05/13 20:02:10
NME

Base Information

Drug NameHSK-31858
Drug Alias NameHSK-31858
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCathepsin C inhibitors
TargetsCathepsin C
Therapy Area/IndicationsRespiratory Distress Syndrome, AdultAcute Lung InjuryPulmonary Disease, Chronic Obstructive +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesHaisco Pharmaceutical Group Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesTibet Haisco Pharmaceutical Co LtdHaisco Pharmaceutical (Australia) Pty LtdChiesi Farmaceutici SPA +[4] 
Inactive CompaniesN/A
Active IndicationsRespiratory Distress Syndrome, AdultAcute Lung InjuryPulmonary Disease, Chronic Obstructive +[5] 
Inactive IndicationsRespiratory Tract Diseases

Other Information

ATC CodeN/A
Related LinksN/A